Initial dosing of sildenafil for PPHN typically starts with 1 to 2 mg/kg intravenously every 6 hours. This is often adjusted based on the infant’s response and clinical condition.
Adjusting the Sildenafil Dose
Careful monitoring of oxygen saturation, blood pressure, and overall clinical picture is crucial for dose adjustments. Increased doses may be considered if there’s insufficient response to the initial dosage. However, increases should be gradual, typically in increments of 1 mg/kg every 6 hours, to minimize adverse events.
- Increased Dose: If improvement is not observed, a cautious increase is warranted, but always under strict clinical supervision. Reduced Dose: Side effects such as hypotension or other complications may necessitate a dose reduction. Always consult the neonatologist’s assessment for appropriate changes.
Maximum doses vary, but exceeding 10 mg/kg/day is generally not recommended. The optimal therapeutic range is individualized and determined by a neonatologist’s evaluation.
Oral Sildenafil Administration
Once the infant is stable enough for oral administration, the physician will determine the appropriate equivalent oral dose. This is usually calculated to maintain a similar plasma concentration to the intravenous dose.
Transition to oral administration is a gradual process, guided by the infant’s clinical progress. Close monitoring continues even after switching to the oral route to ensure optimal efficacy and safety.
Remember: This information is for educational purposes only and does not substitute professional medical advice. Always consult a healthcare professional for diagnosis and treatment of PPHN.
